Parkinson’s Research Program (PRP) – Early Investigator Research Award


U.S Department of Defense Congressionally Directed Medical Research Programs (CDMRP)


Pre-application: 5 PM EST, August 17, 2017

Application: 11:59 PM EST, August 31, 2017


The PRP Early Investigator Research Award (EIRA) mechanism is being offered for the first
time in FY17. The PRP Early Investigator Research Award supports Parkinson’s disease-focused research opportunities for individuals in the early stages of their careers, under the guidance of a designated Mentor.
Consistent with the mission of the FY17 PRP to support research to understand, prevent,
diagnose, and treat Parkinson’s disease in patients, including Service members and Veterans,
investigators are required to address at least one of the following FY17 PRP Focus Areas:
  1. Mechanisms of neuroplasticity in the Parkinson’s disease brain.
  2. Studies to identify gene-environment interactions in Parkinson’s disease cohorts (applications addressing this focus area have an additional submission requirement; please see RFP.
  3. Pathophysiological implications of tau protein in Parkinson’s disease.



 The Early Investigator is considered the Principal Investigator (PI) of the application and must exhibit strong potential for, and commitment to, pursuing a career as an investigator at the forefront of Parkinson’s disease research; however, the PI is not required to have previous Parkinson’s disease research experience. Clinical fellows applying to the PRP EIRA mechanism should be specializing in movement disorders.

The investigator must be a postdoctoral or clinical fellow within three years of advanced degree or residency training (or equivalent) as of the application deadline

Applications must include at least one Mentor, appropriate to the proposed research project, who has experience in Parkinson’s disease research and mentoring as demonstrated by a record of active funding, recent publications, and successful mentorship. The selected Mentor(s) should also demonstrate a clear commitment to the development of the PI toward independence as a Parkinson’s disease researcher.

Available Funding:

The anticipated total (direct plus indirect) costs budgeted for the entire period of performance will not exceed $321,000. The maximum period of performance is two (2) years. The PRP’s FY17 appropriation is $16M.

Link to Full RFP: